ribavirin

1-[(4S,2R,3R,5R)-3,4- dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazole-3- carboxamide 1-[(2R,3R,4S,5R)-3,4- dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-1,2,4-triazole-3-carboxamide 1-((2R,3R,4S,5R)-3,4- dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1H-1,2,4-triazole-3-carboxamide 1-[(2R,3R,4S,5R)-3,4- dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1H-1,2,4-triazol-3-carboxamid 1-[(2R,3R,4S,5R)-3,4- dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1H-1,2,4-triazole-3-carboxamide 1-((2R,3R,4S,5R)-3,4- dihydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-1H-[1,2,4]triazole-3-carboxylic acid amide 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-( hydroxymethyl)oxolan-2-yl]-1,2,4-triazole-3-carboxamide ribavirina ribavirine ribavirinum 1-b-D- ribofuranosyl-1H-1,2,4-triazole-3-carboxamide 1-(b-D- ribofuranosyl)-1H-1,2,4-triazole-3-carboxamide 1H-1,2,4- triazole-3-carboxamide, 1-b-D-ribofuranosyl- 1H-1,2,4- triazole-3-carboxamide, 1-β-D-ribofuranosyl- virazide PubMed: Hepatitis C virus: Virology, diagnosis and treatment. PubMed: Ribavirin Reduces Absolute Lymphocyte Counts in Hepatitis C Virus-Infected Patients Treated With Interferon-Free, Direct-Acting Antiviral Regimens. PubMed: Direct-acting antiviral drug approvals for treatment of chronic hepatitis C virus infection: Scientific and regulatory approaches to clinical trial designs. PubMed: Faldaprevir for the treatment of hepatitis C. PubMed: Preparation of monoPEGylated Cyanovirin-N's derivative and its anti-influenza A virus bioactivity in vitro and in vivo. PubMed: Ribavirin stimulates the immune response of Atlantic salmon. PubMed: Application of "hydrogen bonding interaction" in new drug development: design, synthesis, antiviral activity, and SARs of thiourea derivatives. PubMed: Development of live-attenuated arenavirus vaccines based on codon deoptimization. PubMed: FDA perspective on sofosbuvir therapy for patients with chronic hepatitis C virus genotype 1 infection who did not respond to treatment with pegylated interferon and ribavirin. PubMed: Anti-Mayaro virus activity of Cassia australis extracts (Fabaceae, Leguminosae). PubMed: [A hantavirus killed an Israeli researcher: hazards while working with wild animals]. PubMed: Design, synthesis, and antiviral, fungicidal, and insecticidal activities of tetrahydro-β-carboline-3-carbohydrazide derivatives. PubMed: D and E rings may not be indispensable for antofine: discovery of phenanthrene and alkylamine chain containing antofine derivatives as novel antiviral agents against tobacco mosaic virus (TMV) based on interaction of antofine and TMV RNA. PubMed: Clinical evidence and bioinformatics characterization of potential hepatitis C virus resistance pathways for sofosbuvir. PubMed: Treatment of hepatitis C: a systematic review. PubMed: Antiviral medications for the treatment of hepatitis B and C infection and their effects on kidney function. PubMed: Sofosbuvir for the treatment of chronic hepatitis C virus infection. PubMed: Emerging therapeutic options for the management of hepatitis C infection. PubMed: Hepatitis C in HIV-infected patients: impact of direct-acting antivirals. PubMed: Sofosbuvir: A Nucleotide NS5B Inhibitor for the Treatment of Chronic Hepatitis C Infection. PubMed: Sofosbuvir in the treatment of chronic hepatitis C: new dog, new tricks. PubMed: Synthesis and antiviral and fungicidal activity evaluation of β-carboline, dihydro-β-carboline, tetrahydro-β-carboline alkaloids, and their derivatives. PubMed: [Epidemiology of hepatitis E virus infection in Spain]. PubMed: Antiviral treatment of hepatitis C virus infection and factors affecting efficacy. PubMed: Antiviral activity of polymethoxylated flavones from "Guangchenpi", the edible and medicinal pericarps of citrus reticulata 'Chachi'. PubMed: Sofosbuvir approved for chronic hepatitis C infection. PubMed: New rubrolides from the marine-derived fungus Aspergillus terreus OUCMDZ-1925. PubMed: Sofosbuvir for the treatment of hepatitis C virus. PubMed: Hepatitis E infection in liver transplant recipients. PubMed: Hepatitis E: the forgotten virus. PubMed: Optimizing DAA management in daily practice. PubMed: The pharmacokinetic evaluation of boceprevir for treatment of hepatitis C virus. PubMed: [Biochemical and pharmacological features of telaprevir]. PubMed: Jiawei-Yupingfeng-Tang, a Chinese herbal formula, inhibits respiratory viral infections in vitro and in vivo. PubMed: Safety, tolerability, pharmacokinetics, and antiviral activity of GSK2336805, an inhibitor of hepatitis C virus (HCV) NS5A, in healthy subjects and subjects chronically infected with HCV genotype 1. PubMed: Evolution of cell culture systems for HCV. PubMed: In vivo inhibition of trans-plasma membrane electron transport by antiviral drugs in grapevine. PubMed: A small percentage of patients with hepatitis C receive triple therapy with boceprevir or telaprevir. PubMed: Anti-human rhinovirus 2 activity and mode of action of quercetin-7-glucoside from Lagerstroemia speciosa. PubMed: Telaprevir: clinical pharmacokinetics, pharmacodynamics, and drug-drug interactions. PubMed: Earlier sustained virologic response end points for regulatory approval and dose selection of hepatitis C therapies. PubMed: Arenavirus reverse genetics for vaccine development. PubMed: Boceprevir in chronic hepatitis C infection: a perspective review. PubMed: Boceprevir: a recently approved protease inhibitor for hepatitis C virus infection. PubMed: Establishment of SYBR green-based qPCR assay for rapid evaluation and quantification for anti-Hantaan virus compounds in vitro and in suckling mice. PubMed: Enhanced inhibition of foot-and-mouth disease virus by combinations of porcine interferon-α and antiviral agents. PubMed: Boceprevir: a protease inhibitor for the treatment of hepatitis C. PubMed: Telaprevir: pharmacokinetics and drug interactions. PubMed: Telaprevir: a hepatitis C NS3/4A protease inhibitor. PubMed: Hepatitis in the elderly: still a scourge. PubMed: Design, synthesis, and antiviral activity evaluation of phenanthrene-based antofine derivatives. PubMed: Telaprevir and boceprevir in African Americans with genotype 1 chronic hepatitis C: implications for patients and providers. PubMed: New pharmacotherapy for hepatitis C. PubMed: Therapeutic vaccination against chronic hepatitis C virus infection. PubMed: Ribavirin, a nucleoside with potential insecticidal activity. PubMed: Interferon responsiveness does not change in treatment-experienced hepatitis C subjects: implications for drug development and clinical decisions. PubMed: Protease inhibitors for the treatment of chronic hepatitis C genotype-1 infection: the new standard of care. PubMed: Boceprevir dosing for late responders and null responders: the role of bridging data between treatment-naïve and -experienced subjects. PubMed: New genetic discoveries and treatment for hepatitis C. PubMed: Response-guided telaprevir therapy in prior relapsers? The role of bridging data from treatment-naïve and experienced subjects. PubMed: Advances in the treatment of hepatitis C virus infection. PubMed: Boceprevir: a novel NS3/4 protease inhibitor for the treatment of hepatitis C. PubMed: [Hepatitis E: molecular virology, epidemiology and pathogenesis]. PubMed: A pharmacological profile of ribavirin and monitoring of its plasma concentration in chronic hepatitis C infection. PubMed: The Role of IL28B Genotype Testing in the Era of Direct Acting Antiviral Agents. PubMed: The era of direct-acting antivirals has begun: the beginning of the end for HCV? PubMed: Telaprevir: an oral protease inhibitor for hepatitis C virus infection. PubMed: Quantitative trace analysis of a broad range of antiviral drugs in poultry muscle using column-switch liquid chromatography coupled to tandem mass spectrometry. PubMed: Recent advance in antiviral drugs for hepatitis C. PubMed: FDA notifications. Renal impairment addressed in labeling. PubMed: Management of chronic hepatitis C infection in children. PubMed: Telaprevir: looking for a sustained virologic response in hepatitis C virus infection. PubMed: In vitro activity of Paris polyphylla smith against enterovirus 71 and coxsackievirus B3 and its immune modulation. PubMed: Boceprevir. PubMed: Interferon-lambda and therapy for chronic hepatitis C virus infection. PubMed: Wheezing in infancy. PubMed: Bronchiolitis. PubMed: Hepatitis C pharmacogenetics: state of the art in 2010. PubMed: Current therapies for chronic hepatitis C. PubMed: High-content assay to identify inhibitors of dengue virus infection. PubMed: 5-Methyl-1,2,3-thiadiazoles synthesized via ugi reaction and their fungicidal and antiviral activities. PubMed: Anti-human rhinovirus activity of raoulic acid from Raoulia australis. PubMed: Antimicrobials and the risk of torsades de pointes: the contribution from data mining of the US FDA Adverse Event Reporting System. PubMed: Chronic hepatitis C virus infection in children and adolescents: Epidemiology, natural history, and assessment of the safety and efficacy of combination therapy. PubMed: Taste disturbances during therapy with pegylated interferon-alpha 2b and ribavirin in patients with chronic hepatitis C. PubMed: [Effects of Tankejing dry powder inhaler on the inflammatory damage in the lungs of mice infected by FM1]. PubMed: [Anti-viral effects of Tankejing preparations against influenza virus A]. PubMed: Evidence-based antimicrobial therapy in pregnancy: long overdue. PubMed: Original research: Intravenous ribavirin--review of the FDA's Emergency Investigational New Drug Database (1997-2008) and literature review. PubMed: Effect of dietary purines on the pharmacokinetics of orally administered ribavirin. PubMed: Acrolein, a ubiquitous pollutant and lipid hydroperoxide product, inhibits antiviral activity of interferon-alpha: relevance to hepatitis C. PubMed: Treatment for chronic hepatitis C in children: a review. PubMed: Severe hepatocellular injury with apoptosis induced by a hepatitis C polymerase inhibitor. PubMed: Neuraminidase activity provides a practical read-out for a high throughput influenza antiviral screening assay. PubMed: Hepatitis C: current and future therapies. PubMed: The impact of combination therapy with peginterferon alpha-2a and ribavirin on the energy intake and body weight of adult hepatitis C patients. PubMed: Overcoming hurdles in hepatitis C virus research: efficient production of infectious virus in cell culture. PubMed: Oral lesions in HIV and HCV co-infected individuals in HAART era. PubMed: Stability-indicating thin-layer chromatographic method for quantitative determination of ribavirin. PubMed: Design of the PEDS-C trial: pegylated interferon +/- ribavirin for children with chronic hepatitis C viral infection. PubMed: Gastrointestinal medications in pregnancy. PubMed: Strategies for managing anemia in hepatitis C patients undergoing antiviral therapy. PubMed: Bronchiolitis. PubMed: Hepatitis C (chronic). PubMed: Development of a tomato-based food for special medical purposes as therapy adjuvant for patients with HCV infection. PubMed: Pharmacokinetics of ribavirin in patients with hepatitis C virus. PubMed: Bupleurum kaoi inhibits Coxsackie B virus type 1 infection of CCFS-1 cells by induction of type I interferons expression. PubMed: [Inhibitory effect of new antimicrobial substance by Bacillus subtilis fmbJ on Newcastle disease virus and infectious Bursal disease virus in vitro]. PubMed: FDA approves Pegasys and Copegus for hepatitis C in patients with HIV co-infection. PubMed: Cost-efficacy analysis of peginterferon alfa-2b plus ribavirin compared with peginterferon alfa-2a plus ribavirin for the treatment of chronic hepatitis C. PubMed: Clinical experience with nonstandard doses ofinterferon alfa-2b and ribavirin in the treatment of chronic hepatitis C infection: A retrospective analysis. PubMed: Hepatitis drug gets approval for coinfection treatment. PubMed: The effect of zinc supplementation on the treatment of chronic hepatitis C patients with interferon and ribavirin. PubMed: Oxidative stress in chronic hepatitis C: a preliminary study on the protective effects of antioxidant flavonoids. PubMed: Maintenance therapy for chronic hepatitis C. PubMed: Crimean-Congo hemorrhagic fever. PubMed: Evolution of the HALT-C Trial: pegylated interferon as maintenance therapy for chronic hepatitis C in previous interferon nonresponders. PubMed: Oxidative status in chronic hepatitis C: the influence of antiviral therapy and prognostic value of serum hydroperoxide assay. PubMed: Treatment Options for Hepatitis C Infection in Children. PubMed: Peginterferon alfa-2a: a review of approved and investigational uses. PubMed: FDA approves Hep C drugs. PubMed: Tomato-based functional food as interferon adjuvant in HCV eradication therapy. PubMed: Anti-HCV activities of selective polyunsaturated fatty acids. PubMed: Nucleoside analogues and mitochondrial toxicity. PubMed: Pharmacokinetics and safety of viramidine, a prodrug of ribavirin, in healthy volunteers. PubMed: Hantavirus infection in children. PubMed: Pediatric drug labeling: improving the safety and efficacy of pediatric therapies. PubMed: Pediatric issues in new therapies for hepatitis B and C. PubMed: Hepatitis C: FDA public meeting on peginterferon plus ribavirin, Nov. 14. PubMed: Hepatitis C virus infection. PubMed: Ribavirin and chronic hepatitis C infection. PubMed: Ribavirin for hepatitis C: 80% price reduction available July 9? PubMed: Ribavirin approved with a big fat price. PubMed: Hepatitis C: new treatment overview. PubMed: Treating hepatitis C: a clinician's perspective. Interview by Bob Roehr. PubMed: Can science meet the challenges of the HCV pandemic: new treatment options for chronic hepatitis C. PubMed: Ribavirin approved for hepatitis C combination treatment. PubMed: FDA approves new combination treatment for hepatitis C. Food and Drug Administration. PubMed: Hepatitis C and HIV: ribavirin plus interferon study recruiting. PubMed: Hepatitis C important treatment advance: interview with Douglas Dieterich, M.D. Interview by John S. James. PubMed: Pediatric drug trials: women and children last? PubMed: The clinical pharmacology of ribavirin. PubMed: Underused options for preventing and treating influenza. PubMed: Hepatitis C not incurable. PubMed: From the Food and Drug Administration. PubMed: Evaluation of a rapid diagnostic test for respiratory syncytial virus (RSV): potential for bedside diagnosis. PubMed: Molecular mechanisms of action of ribavirin. PubMed: AIDS drug gets green light. PubMed: Ribavirin aerosol approved for severe cases of RSV in infants and young children.